Literature DB >> 11665585

Identification of adrenergic receptor polymorphisms.

Kersten M Small1, Deborah A Rathz, Stephen B Liggett.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 11665585     DOI： 10.1016/s0076-6879(02)43152-7

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  10 in total

Review 1.  Molecular mechanisms of beta2-adrenergic receptor function and regulation.

Authors:  Dennis W McGraw; Stephen B Liggett
Journal:  Proc Am Thorac Soc       Date:  2005

Review 2.  Alveolar epithelial beta2-adrenergic receptors.

Authors:  Gökhan M Mutlu; Phillip Factor
Journal:  Am J Respir Cell Mol Biol       Date:  2007-08-20       Impact factor: 6.914

3.  Functional adrenergic receptor polymorphisms and idiopathic orthostatic intolerance.

Authors:  R Winker; A Barth; E Valic; R Maier; W Osterode; A Pilger; H W Rüdiger
Journal:  Int Arch Occup Environ Health       Date:  2005-02-18       Impact factor: 3.015

Review 4.  Genetics of beta2-adrenergic receptors and the cardiopulmonary response to exercise.

Authors:  Eric M Snyder; Bruce D Johnson; Michael J Joyner
Journal:  Exerc Sport Sci Rev       Date:  2008-04       Impact factor: 6.230

5.  Adrenergic Polymorphisms and Survival in African Americans With Heart Failure: Results From A-HeFT.

Authors:  Amber E Johnson; Karen Hanley-Yanez; Clyde W Yancy; Anne L Taylor; Arthur M Feldman; Dennis M McNamara
Journal:  J Card Fail       Date:  2019-04-09       Impact factor: 5.712

6.  Single-nucleotide polymorphisms in the β-adrenergic receptor genes are associated with lung allograft utilization.

Authors:  Anil Sapru; Ludmila Pawlikowska; Kathleen D Liu; Kiran K Khush; Lee Ann-Baxter-Lowe; Vanessa Hayden; Rebecca L Menza; Maureen Convery; Annie Poon; Megan Landeck; Jonathan G Zaroff; Michael A Matthay
Journal:  J Heart Lung Transplant       Date:  2011-02       Impact factor: 10.247

7.  Pharmacogenetics and healthcare outcomes in patients with chronic heart failure.

Authors:  Kye-Min Kim; Michael D Murray; Wanzhu Tu; Jason Robarge; Yan Ding; D Craig Brater; David A Flockhart
Journal:  Eur J Clin Pharmacol       Date:  2012-04-29       Impact factor: 2.953

8.  A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure.

Authors:  Stephen B Liggett; Jeanne Mialet-Perez; Surai Thaneemit-Chen; Stewart A Weber; Scott M Greene; Danielle Hodne; Bradley Nelson; Jennifer Morrison; Michael J Domanski; Lynne E Wagoner; William T Abraham; Jeffrey L Anderson; John F Carlquist; Heidi J Krause-Steinrauf; Laura C Lazzeroni; J David Port; Philip W Lavori; Michael R Bristow
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-14       Impact factor: 11.205

9.  Activity of the uptake-1 norepinephrine transporter as measured by I-123 MIBG in heart failure patients with a loss-of-function polymorphism of the presynaptic alpha2C-adrenergic receptor.

Authors:  Myron C Gerson; Lynne E Wagoner; Nancy McGuire; Stephen B Liggett
Journal:  J Nucl Cardiol       Date:  2003 Nov-Dec       Impact factor: 5.952

10.  Beta1- and alpha2c-adrenoreceptor variants as predictors of clinical aspects of dilated cardiomyopathy in people of African ancestry.

Authors:  A J Woodiwiss; D Badenhorst; K Sliwa; R Brooksbank; R Essop; P Sareli; G R Norton
Journal:  Cardiovasc J Afr       Date:  2008 Jul-Aug       Impact factor: 1.167
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.